Join Here   |   Log In

FOLR1 and FOLR2: Transporting Folate, Folinic Acid, and Folic Acid into Cells

Key takeaways:
~ While the reduced folate carrier (SLC19A1) is the dominant folate receptor throughout the body, two other folate receptors enhance folate uptake in a few specific tissues.
~ The folate receptor alpha (FOLR1 gene) is important for the higher folate levels in the cerebrospinal fluid that provide the folate needed in the brain. FOLR2 is important in the immune response.
~ There are a couple of genetic variants and rare mutations that can affect the function of FOLR1 and FOLR2. In addition, antibodies against folate receptor alpha may contribute to cerebral folate deficiency.

Members will see their genotype report below and the solutions in the Lifehacks section. Consider joining today

Folate: Why cells need it an how they get it

Folate, or vitamin B9, is an essential nutrient used by cells for many different processes. When you eat foods that contain folate, natural folate is broken down and absorbed in your intestines and then circulates throughout your body. Folate is needed for the synthesis of DNA, RNA, and amino acids, which are the building blocks of proteins. Cells need a way to take up circulating folate, and there are several receptors that do this.

Bringing folate into the cell:

The main folate receptor found in almost all cell types is SLC19A1 (reduced folate carrier, also called RFC1). However, certain cell types have additional folate receptors that can influence the uptake of folate into tissues.

Graphical abstract of folate receptors
Folate receptors and transporters

FOLR1 and FOLR2 are folate receptors expressed in certain tissues that increase the transport of folate into cells

Receptor Gene Main tissues Function
SLC19A1 SLC19A1 Most tissues General folate transport
Folate receptor alpha (FRα) FOLR1 Placenta, brain, kidney, etc. High-affinity uptake, fetal dev.
Folate receptor beta (FRβ) FOLR2 Immune organs, macrophages Immune response, inflammation
FRγ/δ FOLR3 (Emerging data) Regulatory T-cells (hypothesized)

Let’s take a deeper look at the folate receptors and their functions.

Folate Receptor Alpha (FOLR1):

Expression and Role:

  • Location: Placenta, choroid plexus, kidney, cancer cells
  • Critical for fetal development and brain function
  • Rare FOLR1 mutations cause cerebral folate deficiency
  • Associated symptoms: epilepsy, ataxia, intellectual disability

FOLR1 (folate receptor 1) is the gene encoding folate receptor alpha (FRα). This protein is located on the surface of certain cells and plays a critical role in the uptake and regulation of folate for certain cell types. The FRα protein acts as a receptor that binds to folate and helps transport it into cells. FOLR1 is expressed in several tissues, including the placenta, choroid plexus (where cerebrospinal fluid is produced), and kidneys. It is also found in some cancer cells, most notably ovarian and lung cancers.

Fetal development:
Adequate folate uptake is critical for proper fetal development, particularly for the formation of the neural tube, which gives rise to the brain and spinal cord. The FRα protein plays an important role in this process by facilitating folate transport across the placenta to the developing fetus. FOLR1 can also be secreted as a folate-binding protein in breast milk and semen. In breast milk, this allows folate to be transported to the infant. [ref][ref]

Genetic variations:
Rare mutations in the FOLR1 gene can cause a rare genetic disorder called cerebral folate deficiency (CFD).[ref][ref]

Cancer treatment:
Because some cancer cells overexpress FRα, researchers are looking at ways to target this protein as a potential cancer therapy. One approach involves using antibodies or small molecules that specifically bind to FRα to deliver drugs or imaging agents directly to cancer cells.

Cerebral Folate Deficiency:

Folate is absorbed in the intestines and then circulates in the bloodstream. The bloodstream is separated from the brain and spinal cord to protect these vital organs from pathogens. Therefore, folate must be delivered via receptors to the choroid plexus, the network where cerebrospinal fluid is produced. The FOLR1 receptor is highly expressed on the choroid plexus, and folate concentrations in cerebrospinal fluid are typically about 1.5 times higher than in serum. [ref]

The SLC19A1 transporter (a.k.a. reduced folate carrier or RFC1)  is also found on the choroid plexus for folate transport and is responsible for part of the folate moving into the brain. However, when FOLR1 is impaired by genetic mutations or folate receptor alpha antibodies, there is a reduction in cerebrospinal fluid folate levels because the reduced folate carrier can’t completely compensate for the lack of FOLR1.[ref]

Cerebral folate deficiency syndrome is a neurological syndrome or developmental disorder with low levels of methylfolate (5-MTHF) in the cerebrospinal fluid (CSF) but normal folate levels in the rest of the body. The syndrome may be caused by defective uptake of folate into the CSF due to problems with the FOLR1 receptor. Cerebral folate deficiency can cause neurological disorders such as epilepsy, ataxia, and intellectual disability.[ref][ref]

In addition to reduced folate transport (via FOLR1), other causes of cerebral folate deficiency syndrome include reduced folate storage, metabolic or mitochondrial problems, of increased folate utilization in the brain. Some children with infantile-onset cerebral folate deficiency develop low-IQ autism symptoms.[ref]

Adult-onset cerebral folate deficiency can be caused by mitochondrial diseases, liver disease, or brain calcifications. It can cause movement disorders, ataxia, pyramidal syndrome (spasms, contractions), and cognitive dysfunction. In some people, the condition can be reversed with folinic acid (Leucovorin). [ref][ref]

Schematic of CSF circulation. CC 4.0 image. Mark D. Shen

Folate receptor alpha and autism:

Antibodies against the folate receptor are suspected to play a role in autism, at least for some individuals. A meta-analysis of studies on cerebral folate deficiency found that its prevalence was 38% in autism spectrum disorder. Folate receptor alpha antibodies were thought to be the cause of cerebral folate deficiency in 83% of cases.[ref]

In children with cerebral folate deficiency and folate receptor antibodies, treatment with folinic acid (d,l-leucovorin) significantly improved autism symptoms.[ref]

Folate receptor beta (FOLR2):

Expression and Role

  • Found in hematopoietic tissue and activated macrophages
  • Overexpressed in some cancers and autoimmune diseases

The FOLR2 gene codes for folate receptor beta (FRβ).  FOLR2 is primarily expressed in hematopoietic (blood-forming) tissues, such as the spleen, thymus, and bone marrow. FRβ is also found on the surface of activated macrophages, which are immune cells involved in the body’s defense against pathogens and in inflammation.

Inflammation, fibrosis, and autoimmunity:
Folate receptor beta (FOLR2) expression is upregulated in activated macrophages during inflammation and in some autoimmune diseases, such as rheumatoid arthritis. Activated M2 macrophages increase fibrosis and growth by secreting lots of TGF-beta, and researchers are looking at blocking FOLR2 in autoimmune diseases to reduce macrophage activity.[ref]

Cancer:
Like FRα, FRβ is also overexpressed in some cancer cells, particularly in myeloid leukemia and in tumor-associated macrophages (TAMs). TAMs are macrophages that are recruited to the tumor microenvironment and can promote tumor growth, angiogenesis (blood vessel formation), and metastasis. Overexpression of FRβ in these cells makes it a potential target for cancer therapy.[ref]

Genetic disorders:
While there are some rare mutations in FOLR1 associated with cerebral folate deficiency, there are currently no known genetic disorders specifically linked to mutations in the FOLR2 gene.

 


Genotype report: FOLR1 and FOLR2

Mutations and SNPs in FOLR1 and FOLR2 are uncommon. These are key receptors for folate in the brain during development, so more significant changes to the gene are likely incompatible with life.[ref] FOLR1 gene: encodes the folate receptor alpha, which is a cell receptor that transports in folate for certain cell types.

Check your genetic data for rs144637717 (23andMe v4, v5; AncestryDNA):

  • T/T: typical
  • C/T: cerebral folate deficiency possible[ref], especially in conjunction with a second mutation
  • C/C: cerebral folate deficiency possible[ref]

Members: Your genotype for rs144637717 is .

Check your genetic data for rs1540087 (AncestryDNA):

  • G/G: typical
  • A/G: lower odds of skin lesions with arsenic exposure (methyl groups are utilized for arsenic detoxification, better methylation cycle)
  • A/A: lower odds of skin lesions with arsenic exposure (methyl groups are utilized for arsenic detoxification, better methylation cycle)[ref] (good)

Members: Your genotype for rs1540087 is .

Check your genetic data for rs2071010 (23andMe v4, AncestryDNA):

  • A/A: slightly increased relative risk of congenital heart disease in offspring[ref][ref] increased  relative risk of high homocysteine[ref]
  • A/G: typical risk
  • G/G: typical

Members: Your genotype for rs2071010 is .

FOLR2 gene:

Check your genetic data for rs514933 (AncestryDNA):

  • C/C: reduced relative risk of congenital heart disease in offspring[ref] (good)
  • C/T: reduced relative risk of congenital heart disease in offspring
  • T/T: typical

Members: Your genotype for rs514933 is .

Are there other folate receptors?
Yes. There is also Folate Receptor-gamma (FRγ) and FR-delta (FRδ, FOLR3), but their function isn’t fully known or understood – yet. Folate receptor-delta is likely important in regulatory T-cells.[ref]


Lifehacks:

Track: If you have a folate receptor variant, look at how much folate you get from natural foods containing folate as well as how much folic acid you get from fortified foods. Cronometer.com is a free web app that lets you track your nutrient intake from foods that you eat. You may be surprised at how much (or little) folate you consume.

Caution with high doses: While there are specific reasons for high doses of folate supplements, such as cerebral folate deficiency, the flip side is the use of folate by cancerous cells. In my opinion, folate supplements should be approached with some caution in people who are at risk for cancer. Talk with your doctor if you have any questions about supplements.

Access this content:

An active subscription is required to access this content.

Join as a member



Related articles and topics:

Homocysteine: Genetics, High Homocysteine Levels, and Solutions

Riboflavin (Vitamin B2), MTHFR, and Deficiency Symptoms

 

References:

Akiyama, Mari, et al. “Determination of CSF 5-Methyltetrahydrofolate in Children and Its Application for Defects of Folate Transport and Metabolism.” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 460, Sept. 2016, pp. 120–25. PubMed, https://doi.org/10.1016/j.cca.2016.06.032.
Cao, Xuanye, et al. “CIC de Novo Loss of Function Variants Contribute to Cerebral Folate Deficiency by Downregulating FOLR1 Expression.” Journal of Medical Genetics, vol. 58, no. 7, July 2021, pp. 484–94. PubMed Central, https://doi.org/10.1136/jmedgenet-2020-106987.
Desai, Ankuri, et al. “The Metabolic Basis for Developmental Disorders Due to Defective Folate Transport.” Biochimie, vol. 126, July 2016, pp. 31–42. PubMed, https://doi.org/10.1016/j.biochi.2016.02.012.
Holm, Jan, and Steen Ingemann Hansen. “Characterization of Soluble Folate Receptors (Folate Binding Proteins) in Humans. Biological Roles and Clinical Potentials in Infection and Malignancy.” Biochimica Et Biophysica Acta. Proteins and Proteomics, vol. 1868, no. 10, Oct. 2020, p. 140466. PubMed, https://doi.org/10.1016/j.bbapap.2020.140466.
Manco, Carlo, et al. “FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years.” Neurology: Genetics, vol. 9, no. 6, Oct. 2023, p. e200104. PubMed Central, https://doi.org/10.1212/NXG.0000000000200104.
Mangold, Sarah, et al. “Cerebral Folate Deficiency: A Neurometabolic Syndrome?” Molecular Genetics and Metabolism, vol. 104, no. 3, Nov. 2011, pp. 369–72. PubMed, https://doi.org/10.1016/j.ymgme.2011.06.004.
Masingue, Marion, et al. “Cerebral Folate Deficiency in Adults: A Heterogeneous Potentially Treatable Condition.” Journal of the Neurological Sciences, vol. 396, Jan. 2019, pp. 112–18. PubMed, https://doi.org/10.1016/j.jns.2018.11.014.
McCreary, Dara, et al. “Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation.” JAMA Network Open, vol. 2, no. 10, Oct. 2019, p. e1914274. PubMed Central, https://doi.org/10.1001/jamanetworkopen.2019.14274.
Niedzwiecki, Megan M., et al. “Serum Homocysteine, Arsenic Methylation, and Arsenic-Induced Skin Lesion Incidence in Bangladesh: A One-Carbon Metabolism Candidate Gene Study.” Environment International, vol. 113, Apr. 2018, pp. 133–42. PubMed Central, https://doi.org/10.1016/j.envint.2018.01.015.
Qu, Yaqian, et al. “Folate and Macrophage Folate Receptor-β in Idiopathic Pulmonary Fibrosis Disease: The Potential Therapeutic Target?” Biomedicine & Pharmacotherapy, vol. 131, Nov. 2020, p. 110711. ScienceDirect, https://doi.org/10.1016/j.biopha.2020.110711.
Ramaekers, Vincent Th., and Edward V. Quadros. “Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies.” Nutrients, vol. 14, no. 15, July 2022, p. 3096. PubMed Central, https://doi.org/10.3390/nu14153096.
———. “Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies.” Nutrients, vol. 14, no. 15, July 2022, p. 3096. PubMed Central, https://doi.org/10.3390/nu14153096.
———. “Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies.” Nutrients, vol. 14, no. 15, July 2022, p. 3096. PubMed Central, https://doi.org/10.3390/nu14153096.
Rossignol, Daniel A., and Richard E. Frye. “Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.” Journal of Personalized Medicine, vol. 11, no. 11, Nov. 2021, p. 1141. PubMed Central, https://doi.org/10.3390/jpm11111141.
———. “Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.” Journal of Personalized Medicine, vol. 11, no. 11, Nov. 2021, p. 1141. PubMed Central, https://doi.org/10.3390/jpm11111141.
Samaniego, Rafael, et al. “Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1.” Cells, vol. 9, no. 6, June 2020, p. 1445. PubMed Central, https://doi.org/10.3390/cells9061445.
Sangha, Vishal, et al. “Protective Effects of Pyrroloquinoline Quinone in Brain Folate Deficiency.” Fluids and Barriers of the CNS, vol. 20, Nov. 2023, p. 84. PubMed Central, https://doi.org/10.1186/s12987-023-00488-3.
Seelan, RS, et al. “Gestational Folate Deficiency Alters Embryonic Gene Expression and Cell Function.” Differentiation; Research in Biological Diversity, vol. 117, 2021, pp. 1–15. PubMed Central, https://doi.org/10.1016/j.diff.2020.11.001.
Song, Xinli, Peng Huang, et al. “Association of Periconceptional Folate Supplements and FOLR1 and FOLR2 Gene Polymorphisms with Risk of Congenital Heart Disease in Offspring: A Hospital-Based Case-Control Study.” Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences, vol. 47, no. 1, Jan. 2022, pp. 52–62. PubMed, https://doi.org/10.11817/j.issn.1672-7347.2022.200992.
———. “Association of Periconceptional Folate Supplements and FOLR1 and FOLR2 Gene Polymorphisms with Risk of Congenital Heart Disease in Offspring: A Hospital-Based Case-Control Study.” Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences, vol. 47, no. 1, Jan. 2022, pp. 52–62. PubMed, https://doi.org/10.11817/j.issn.1672-7347.2022.200992.
Song, Xinli, Jianhui Wei, et al. “Association of Polymorphisms of FOLR1 Gene and FOLR2 Gene and Maternal Folic Acid Supplementation with Risk of Ventricular Septal Defect: A Case-Control Study.” European Journal of Clinical Nutrition, vol. 76, no. 9, Sept. 2022, pp. 1273–80. PubMed, https://doi.org/10.1038/s41430-022-01110-9.
Steinz, Maarten M., et al. “Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis.” Frontiers in Immunology, vol. 13, Feb. 2022, p. 819163. PubMed Central, https://doi.org/10.3389/fimmu.2022.819163.
Zhang, Ciliu, et al. “First Case Report of Cerebral Folate Deficiency Caused by a Novel Mutation of FOLR1 Gene in a Chinese Patient.” BMC Medical Genetics, vol. 21, Nov. 2020, p. 235. PubMed Central, https://doi.org/10.1186/s12881-020-01162-3.
Zhu, Huiping, et al. “Cardiovascular Abnormalities in Folr1 Knockout Mice and Folate Rescue.” Birth Defects Research. Part A, Clinical and Molecular Teratology, vol. 79, no. 4, Apr. 2007, pp. 257–68. PubMed, https://doi.org/10.1002/bdra.20347.
Zhu, Shaofang, et al. “Genetic Polymorphisms in Enzymes Involved in One-Carbon Metabolism and Anti-Epileptic Drug Monotherapy on Homocysteine Metabolism in Patients With Epilepsy.” Frontiers in Neurology, vol. 12, June 2021, p. 683275. PubMed Central, https://doi.org/10.3389/fneur.2021.683275.

About the Author:
Debbie Moon is a biologist, engineer, author, and the founder of Genetic Lifehacks where she has helped thousands of members understand how to apply genetics to their diet, lifestyle, and health decisions. With more than 10 years of experience translating complex genetic research into practical health strategies, Debbie holds a BS in engineering from Colorado School of Mines and an MSc in biological sciences from Clemson University. She combines an engineering mindset with a biological systems approach to explain how genetic differences impact your optimal health.